These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20847434)

  • 21. Future screening for incipient Alzheimer's disease--the influence of prevalence on test performance.
    Mattsson N; Zetterberg H
    Eur Neurol; 2009; 62(4):200-3. PubMed ID: 19602894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the early detection of Alzheimer's disease.
    Nestor PJ; Scheltens P; Hodges JR
    Nat Med; 2004 Jul; 10 Suppl():S34-41. PubMed ID: 15298007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting amyloid-β plaques in Alzheimer's disease.
    Baltes C; Princz-Kranz F; Rudin M; Mueggler T
    Methods Mol Biol; 2011; 711():511-33. PubMed ID: 21279620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent advances in Alzheimer's disease research].
    Hirai S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Apr; 18(2):55-61. PubMed ID: 9656234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular Biomarkers in Alzheimer's Disease: Insights into Early Detection Through Eye-Based Diagnostics - A Literature Review.
    Firmani G; Salducci M; Testa F; Covelli GP; Sagnelli P; Lambiase A
    Clin Ter; 2024; 175(5):352-361. PubMed ID: 39400101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions.
    Dehghani C; Frost S; Jayasena R; Masters CL; Kanagasingam Y
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3554-3563. PubMed ID: 30025102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal manifestations of Alzheimer's disease.
    Dehabadi MH; Davis BM; Wong TK; Cordeiro MF
    Neurodegener Dis Manag; 2014; 4(3):241-52. PubMed ID: 25095818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease.
    Ikram MK; Cheung CY; Wong TY; Chen CP
    J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):917-22. PubMed ID: 22733082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease.
    Singh AK; Verma S
    Indian J Ophthalmol; 2020 Apr; 68(4):555-561. PubMed ID: 32174567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease.
    Sivak JM
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):871-80. PubMed ID: 23364356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease.
    Prvulovic D; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):517-9. PubMed ID: 22137044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new controlled concept of immune-sensing platform for specific detection of Alzheimer's biomarkers.
    Ammar M; Smadja C; Giang Thi Phuong L; Azzouz M; Vigneron J; Etcheberry A; Taverna M; Dufour-Gergam E
    Biosens Bioelectron; 2013 Feb; 40(1):329-35. PubMed ID: 22981833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Near-infrared Fluorescence Ocular Imaging (NIRFOI) of Alzheimer's Disease.
    Yang J; Yang J; Li Y; Xu Y; Ran C
    Mol Imaging Biol; 2019 Feb; 21(1):35-43. PubMed ID: 29802553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glia-Mediated Retinal Neuroinflammation as a Biomarker in Alzheimer's Disease.
    Madeira MH; Ambrósio AF; Santiago AR
    Ophthalmic Res; 2015; 54(4):204-11. PubMed ID: 26517861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease.
    Tian T; Zhang B; Jia Y; Li Z
    Dis Markers; 2014; 2014():826503. PubMed ID: 24688166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and Prognostic Potential of Retinal Biomarkers in Early On-Set Alzheimer's Disease.
    Shariflou S; Georgevsky D; Mansour H; Rezaeian M; Hosseini N; Gani F; Gupta V; Braidy N; Golzan SM
    Curr Alzheimer Res; 2017; 14(9):1000-1007. PubMed ID: 28356048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: Present and future applications.
    Reale M; Gonzales-Portillo I; Borlongan CV
    Brain Res; 2020 Jan; 1727():146535. PubMed ID: 31669827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration.
    Romaus-Sanjurjo D; Regueiro U; López-López M; Vázquez-Vázquez L; Ouro A; Lema I; Sobrino T
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.